Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: A systematic review and meta-analysis

被引：51

作者：

Alghamdi, AA ^{[1
]}

Al-Radi, OO ^{[1
]}

Latter, DA ^{[1
]}

机构：

[1] Univ Toronto, Dept Surg, Div Cardiac Surg, Toronto, ON, Canada

来源：

JOURNAL OF CARDIAC SURGERY | 2005年 / 20卷 / 03期

关键词：

D O I：

10.1111/j.1540-8191.2005.200447.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is one of the most common complications after coronary artery bypass surgery. The objective of this study was to assess the effectiveness of intravenous magnesium in preventing postoperative atrial fibrillation. A meta-analysis of eight identified randomized controlled trials, reporting comparisons between magnesium and control was undertaken. The primary outcome was incidence of postoperative atrial fibrillation. Our review revealed that use of intravenous magnesium is associated with a significant reduction in the incidence of atrial fibrillation after coronary artery bypass surgery, with a relative risk of 0.64 (95% confidence interval = 0.47, 0.87, and p = 0.004).

引用

页码：293 / 299

页数：7

共 43 条

[41] Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group
van Tulder, M
Furlan, A
Bombardier, C
Bouter, L
[J]. SPINE, 2003, 28 (12) : 1290 - 1299
[42] Correction of ionized plasma magnesium during cardiopulmonary bypass reduces the risk of postoperative cardiac arrhythmia
Wilkes, NJ
Mallett, SV
Peachy, T
Di Salvo, C
Walesby, R
[J]. ANESTHESIA AND ANALGESIA, 2002, 95 (04) : 828 - 834
[43] Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery - A meta-analysis
Wurdeman, RL
Mooss, AN
Mohiuddin, SM
Lenz, TL
[J]. CHEST, 2002, 121 (04) : 1203 - 1210

← 1 2 3 4 5 →